FdaApplication
ANDA 075416
Identifiers
- fda_app_no: ANDA075416
Properties
| Property | Value |
|---|---|
| applicant_name | ACTAVIS LABORATORIES FL INC |
| application_type | ANDA |
| approval_date | 2002-08-27 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NAPROXEN SODIUM | NAPROXEN SODIUM | EQ 750MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| NAPROXEN SODIUM | NAPROXEN SODIUM | EQ 500MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| NAPROXEN SODIUM | NAPROXEN SODIUM | EQ 375MG BASE | TABLET, EXTENDED RELEASE;ORAL |
3 products